News for Healthier Living

Cleveland Clinic Researchers Build First Large-Scale Atlas of How Immune Cells React to Mutations During Cancer Immunotherapy

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, PhD, Chair of Cleveland Clinic's Global Center for Immunotherapy, and Bristol Myers Squibb has published the most comprehensive overview to date of how our immune system reshapes tumor architecture in response to immune checkpoint therapy. The eight-year study, published in Nature Medicine, outlines how cancer immunotherapy induces tumor recognition through neoantigens to reshape the tumor ecosystem.

October 1, 2024


October 5 2024

October 4 2024

October 3 2024

October 2 2024

October 1 2024

September 30 2024

September 29 2024

September 28 2024

September 27 2024

September 26 2024

September 25 2024

September 24 2024

September 23 2024

September 22 2024

September 21 2024